Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × Disulfides × 1 year × Clear all

Sponsor

Conditions

Lung Neoplasms 21 Carcinoma, Non-Small-Cell Lung 15 Ovarian Neoplasms 11 Fallopian Tube Neoplasms 11 Colorectal Neoplasms 8 Urinary Bladder Neoplasms 6 Pancreatic Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 6 Carcinoma, Hepatocellular 6 Mycosis Fungoides 5 Melanoma 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm Metastasis 4 Lymphoma, T-Cell, Cutaneous 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Glioblastoma 4 Carcinoma, Renal Cell 4 Breast Neoplasms 4 Sezary Syndrome 3 Nasopharyngeal Carcinoma 3 Mouth Neoplasms 3 Lymphoma, T-Cell 3 Lymphoma, B-Cell 3 Carcinoma 3 Brain Neoplasms 3 Urogenital Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2

Interventions

Specimen Handling 7 Biopsy 6 Cyclophosphamide 5 ruxolitinib 4 Mycophenolic Acid 4 Busulfan 4 fludarabine phosphate 3 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Melphalan 3 Injections 3 Decitabine 3 Cyclosporine 3 Azacitidine 3 venetoclax 2 decitabine and cedazuridine drug combination 2 Sirolimus 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 veliparib 1 tocilizumab 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 gilteritinib 1 fedratinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡